Follow
Dr. Jamsheed Javid
Dr. Jamsheed Javid
Assistant Professor, Faculty of Applied Medical Sciences, University of Tabuk, KSA
Verified email at ut.edu.sa
Title
Cited by
Cited by
Year
Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features
M Zuberi, R Mir, J Das, I Ahmad, J Javid, P Yadav, M Masroor, S Ahmad, ...
Clinical and Translational Oncology 17, 779-787, 2015
1502015
Extracellular cytochrome c as a biomarker for monitoring therapeutic efficacy and prognosis of non-small cell lung cancer patients
J Javid, R Mir, PK Julka, PC Ray, A Saxena
Tumor Biology 36, 4253-4260, 2015
392015
Clinical significance of circulatory miRNA-21 as an efficient non-invasive biomarker for the screening of lung cancer patients
FM Abu-Duhier, J Javid, MA Sughayer, R Mir, T Albalawi, MS Alauddin
Asian Pacific journal of cancer prevention: APJCP 19 (9), 2607, 2018
372018
Simple multiplex RT-PCR for identifying common fusion BCR-ABL transcript types and evaluation of molecular response of the a2b2 and a2b3 transcripts to Imatinib resistance in …
R Mir, I Ahmad, J Javid, M Zuberi, P Yadav, R Shazia, M Masroor, S Guru, ...
Indian journal of cancer 52 (3), 314-318, 2015
342015
Evaluation of the association of omentin 1 rs2274907 a> t and rs2274908 g> a gene polymorphisms with coronary artery disease in Indian population: a case control study
CK Jha, R Mir, I Elfaki, J Javid, AT Babakr, S Banu, SMS Chahal
Journal of personalized medicine 9 (2), 30, 2019
332019
Potential impact of microRNA-423 gene variability in coronary artery disease
CK Jha, R Mir, I Elfaki, N Khullar, S Rehman, J Javid, S Banu, S Chahal
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2019
262019
The promising signatures of circulating microRNA-145 in epithelial ovarian cancer patients
M Zuberi, R Mir, I Khan, J Javid, SA Guru, M Bhat, MP Sumi, I Ahmad, ...
MicroRNA 9 (1), 49-57, 2020
232020
Association of p53 and mdm2 in the development and progression of non-small cell lung cancer
J Javid, R Mir, PK Julka, PC Ray, A Saxena
Tumor Biology 36, 5425-5432, 2015
232015
RASSF1 and PTEN promoter hypermethylation influences the outcome in epithelial ovarian cancer
M Zuberi, R Mir, S Dholariya, I Najar, P Yadav, J Javid, S Guru, M Mirza, ...
Clinical Ovarian and Other Gynecologic Cancer 7 (1-2), 33-39, 2014
182014
Incidence of MicroR-4513C/T gene variability in coronary artery disease-a case-control study
R Mir, I Elfaki, J Javid, S Rehman, N Khullar, S Banu, SMS Chahal
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2019
172019
Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients
P Yadav, M Masroor, K Tanwer, R Mir, J Javid, I Ahmad, M Zuberi, ...
Clinical and Translational Oncology 18, 728-734, 2016
162016
CC genotype of anti-apoptotic gene BCL-2 (− 938 C/A) is an independent prognostic marker of unfavorable clinical outcome in patients with non-small-cell lung cancer
J Javid, R Mir, M Mirza, A Imtiyaz, Y Prasant, Z Mariyam, PK Julka, ...
Clinical and Translational Oncology 17, 289-295, 2015
162015
Role of survivin re-expression in the development and progression of non-small cell lung cancer
J Javid, R Mir, PK Julka, PC Ray, A Saxena
Tumor Biology 36, 5543-5550, 2015
132015
Clinical implication of EGF A61G polymorphism in the risk of non small cell lung adenocarcinoma patients: a case control study
M Masroor, J Amit, J Javid, R Mir, Y Prasant, A Imtiyaz, Z Mariyam, ...
Asian Pacific Journal of Cancer Prevention 16 (17), 7529-7534, 2015
122015
Potential Impact of COMT-rs4680 G > A Gene Polymorphism in Coronary Artery Disease
R Mir, M Bhat, J Javid, C Jha, A Saxena, S Banu
Journal of cardiovascular development and disease 5 (3), 38, 2018
112018
Molecular evaluation of MicroRNA-146 Gene Variability (rs2910164 C> G) and its association with increased susceptibility to coronary artery disease
R Mir, I Elfaki, C Jha, J Javid, S Rehman, S Banu, MM Mir, AT Babakr, ...
Microrna 9 (5), 363-372, 2020
102020
A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population
R Mir, J Javid, IA Al Balawi, KR Alkharsah, MA Hadi, MA Rahman, ...
Asian Pacific journal of cancer prevention: APJCP 19 (3), 859-866, 2018
102018
MicroRNA-224 (rs188519172 A> G) gene variability is associated with a decreased susceptibility to coronary artery disease: A case-control study
R Mir, CK Jha, I Elfaki, S Rehman, J Javid, N Khullar, S Banu, S Chahal
Microrna 8 (3), 198-205, 2019
92019
Epigenetic silencing of DAPK1 gene is associated with faster disease progression in India populations with chronic myeloid leukemia
R Mir, I Ahmad, J Javid, S Farooq, P Yadav
J Cancer Sci Ther 5, 144-149, 2013
92013
Biological and Clinical Implications of TNF-α Promoter and CYP1B1 Gene Variations in Coronary Artery Disease Susceptibility
R Mir, I Elfaki, CK Jha, J Javid, AT Babakr, S Banu, MM Mir, D Jamwal, ...
Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current …, 2021
82021
The system can't perform the operation now. Try again later.
Articles 1–20